In a report released on August 7, Puneet Souda from Leerink Partners maintained a Buy rating on Myriad Genetics (MYGN – Research Report), with a price target of $35.00. Puneet Souda has given his Buy ...
O’Ryan Health is turning every home into a safe, reliable point of care. This partnership with Aura Genetics will accelerate access for families where travel to a lab can be a major obstacle.” — Tim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results